Literature DB >> 19892059

Optimization of the interventricular delay in cardiac resynchronization therapy using the QRS width.

David Tamborero1, Lluís Mont, Marta Sitges, Etelvino Silva, Antonio Berruezo, Barbara Vidal, Victoria Delgado, Jose M Tolosana, Miguel Godoy, Angeles Castel, Josep Brugada.   

Abstract

Optimization of the interventricular pacing delay (VV) in cardiac resynchronization therapy is time-consuming and not routinely performed. The aim of the present study was to compare the acute hemodynamic response obtained by different VV programming methods. Several methods for optimizing the VV using electrocardiographic or echocardiographic measurements were performed. The effect of programming an empirical prefixed VV of 0 ms was also evaluated. Invasive first derivative of left ventricular (LV) pressure over time (dP/dt max) was measured at several VV values, and the hemodynamic response that could be obtained by each noninvasive VV selection method was extrapolated from the curve of LV dP/dt max versus VV. The study included 25 patients (80% men, age 66 +/- 9 years, 44% ischemic). The maximum achievable LV dP/dt during biventricular pacing was obtained by a median left ventricular preactivation of 30 ms and increased the baseline unpaced LV dP/dt from 774 +/- 181 to 934 +/- 179 mm Hg/s (p <0.001). The noninvasive optimization method selected the VV leading to the narrowest QRS measured from the earliest deflection and obtained the smallest difference with regard to the maximum achievable LV dP/dt. Furthermore, of all the VV optimization methods tested, this was the only 1 that significantly improved on the hemodynamic response obtained by programming a predefined VV of 0 ms in all patients (925 +/- 178 vs 906 +/- 183 mm Hg/s; p = 0.003). In conclusion, achieving the narrowest QRS measured from the earliest deflection obtained a better acute hemodynamic response than the other VV optimization methods. It also improved the response obtained by default simultaneous biventricular pacing, although this improvement was limited in magnitude.

Entities:  

Mesh:

Year:  2009        PMID: 19892059     DOI: 10.1016/j.amjcard.2009.07.006

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

Authors:  Laszlo Buga
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

2.  Incidence, predictors, and impact on outcome of increased left ventricular latency in patients undergoing cardiac resynchronization therapy.

Authors:  Antonio D'Onofrio; Salvatore Ivan Caico; Assunta Iuliano; Paolo Pieragnoli; Valter Bianchi; Daniela Orsida; Antonio Pani; Mario Pasqualini; Francesca Amadori; Ludovico Vasquez; Antonello Talarico; Chiara Minoia; Roberto Ospizio; Greta Merlotti; Maurizio Malacrida; Giuseppe Stabile
Journal:  J Interv Card Electrophysiol       Date:  2018-03-03       Impact factor: 1.900

3.  Precision of automated QRS duration measurement in patients treated with cardiac resynchronization therapy.

Authors:  Casper Lund-Andersen; Helen H Petersen; Christian Jøns; Berit T Philbert; Jacob Tfelt-Hansen; Lene T Skovgaard; Jesper H Svendsen
Journal:  J Interv Card Electrophysiol       Date:  2018-03-05       Impact factor: 1.900

4.  Reproducibility of measuring QRS duration and implications for optimization of interventricular pacing delay in cardiac resynchronization therapy.

Authors:  Charlotte Stephansen; Mads Brix Kronborg; Christoffer Tobias Witt; Jens Kristensen; Christian Gerdes; Anders Sommer; Jesper Møller Jensen; Jens Cosedis Nielsen
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-12-06       Impact factor: 1.468

Review 5.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

6.  A systematic approach to designing reliable VV optimization methodology: assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy.

Authors:  Andreas Kyriacou; Matthew E Li Kam Wa; Punam A Pabari; Beth Unsworth; Resham Baruah; Keith Willson; Nicholas S Peters; Prapa Kanagaratnam; Alun D Hughes; Jamil Mayet; Zachary I Whinnett; Darrel P Francis
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

7.  Septal flash correction with His-Purkinje pacing predicts echocardiographic response in resynchronization therapy.

Authors:  Margarida Pujol-López; Rafael Jiménez Arjona; Eduard Guasch; Adelina Doltra; Roger Borràs; Ivo Roca Luque; María Ángeles Castel; Paz Garre; Elisenda Ferró; Mireia Niebla; Esther Carro; Elena Arbelo; Marta Sitges; José M Tolosana; Lluís Mont
Journal:  Pacing Clin Electrophysiol       Date:  2022-01-29       Impact factor: 1.912

8.  Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT).

Authors:  Charlotte Stephansen; Anders Sommer; Mads Brix Kronborg; Jesper Møller Jensen; Kirsten Bouchelouche; Jens Cosedis Nielsen
Journal:  Trials       Date:  2018-11-01       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.